The proportion of patients achieving (A) clinical response, (B) endoscopic improvement at week 12 (pooled) and week 52 (ELEVATE UC 52), and (C) corticosteroid-free clinical remission at week 52 (ELEVATE UC 52) in the ELEVATE UC clinical program, stratified by age (FAS with baseline MMS 5-9). *P < .05, **P < .01, ***P < .001. Abbreviations: Δ, adjusted difference from placebo; CI, confidence interval; FAS, full analysis set; MMS, modified Mayo score; n, number of patients meeting each endpoint; N, number of patients in FAS; QD, once daily; UC, ulcerative colitis.